Effect of inhalation of tiotropium once daily 18 mcg versus salmeterol twice daily 50 mcg on time to first exacerbation in COPD [chronic obstructive pulmonary disease] patients (a randomized, double-blind, double-dummy, parallel group, one-year study).

Trial Profile

Effect of inhalation of tiotropium once daily 18 mcg versus salmeterol twice daily 50 mcg on time to first exacerbation in COPD [chronic obstructive pulmonary disease] patients (a randomized, double-blind, double-dummy, parallel group, one-year study).

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Feb 2017

At a glance

  • Drugs Tiotropium bromide (Primary) ; Salmeterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms POET; POET-COPD
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 14 Jun 2012 Results of a German cost-effectiveness analysis published in the European Respiratory Journal.
    • 28 Sep 2011 Results of an economic analysis presented at the 21st Annual Congress of the European Respiratory Society.
    • 25 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top